These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4335 related items for PubMed ID: 7516926

  • 1. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
    Topalian SL, Rivoltini L, Mancini M, Ng J, Hartzman RJ, Rosenberg SA.
    Int J Cancer; 1994 Jul 01; 58(1):69-79. PubMed ID: 7516926
    [Abstract] [Full Text] [Related]

  • 2. Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.
    Topalian SL, Rivoltini L, Mancini M, Markus NR, Robbins PF, Kawakami Y, Rosenberg SA.
    Proc Natl Acad Sci U S A; 1994 Sep 27; 91(20):9461-5. PubMed ID: 7937789
    [Abstract] [Full Text] [Related]

  • 3. A human melanoma cell line, recognized by both HLA class I and class II restricted T cells, is capable of initiating both primary and secondary immune responses.
    Olsen AC, Fossum B, Kirkin AF, Zeuthen J, Gaudernack G.
    Scand J Immunol; 1995 Apr 27; 41(4):357-64. PubMed ID: 7899823
    [Abstract] [Full Text] [Related]

  • 4. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.
    Hom SS, Topalian SL, Simonis T, Mancini M, Rosenberg SA.
    J Immunother (1991); 1991 Jun 27; 10(3):153-64. PubMed ID: 1868040
    [Abstract] [Full Text] [Related]

  • 5. Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.
    Robbins PF, El-Gamil M, Li YF, Zeng G, Dudley M, Rosenberg SA.
    J Immunol; 2002 Nov 15; 169(10):6036-47. PubMed ID: 12421991
    [Abstract] [Full Text] [Related]

  • 6. A CD4+, HLA-DR7-restricted T-helper lymphocyte clone recognizes an antigen shared by human malignant melanoma and glioma.
    Somasundaram R, Swoboda R, Caputo L, Lee A, Jackson N, Marincola FM, Guerry D, Herlyn D.
    Int J Cancer; 2003 Apr 10; 104(3):362-8. PubMed ID: 12569560
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response.
    Sugano M, Conway TF, Kelleher RJ, Sugiyama Y, Chen FA, Bankert RB, Bernstein SH.
    J Exp Clin Cancer Res; 2001 Jun 10; 20(2):175-82. PubMed ID: 11484971
    [Abstract] [Full Text] [Related]

  • 10. T cell-receptor V gene use by CD4+ melanoma-reactive clonal and oligoclonal T-cell lines.
    Nishimura MI, Custer MC, Schwarz SL, Parker LL, Mixon A, Clay TM, Yannelli JR, Rosenberg SA.
    J Immunother; 1998 Sep 10; 21(5):352-62. PubMed ID: 9789197
    [Abstract] [Full Text] [Related]

  • 11. HLA class II-restricted recognition of common tumor epitopes on human melanoma cells by CD4+ melanoma-infiltrating lymphocytes.
    Le Dréan E, Gervois N, Diez E, Semana G, Dreno B, Jotereau F.
    Eur J Immunol; 1995 Oct 10; 25(10):2732-6. PubMed ID: 7589064
    [Abstract] [Full Text] [Related]

  • 12. Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen.
    Novellino L, Renkvist N, Rini F, Mazzocchi A, Rivoltini L, Greco A, Deho P, Squarcina P, Robbins PF, Parmiani G, Castelli C.
    J Immunol; 2003 Jun 15; 170(12):6363-70. PubMed ID: 12794170
    [Abstract] [Full Text] [Related]

  • 13. Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules.
    Parkhurst MR, DePan C, Riley JP, Rosenberg SA, Shu S.
    J Immunol; 2003 May 15; 170(10):5317-25. PubMed ID: 12734382
    [Abstract] [Full Text] [Related]

  • 14. Tumor-specific T-cell clones recognize different protein determinants of autologous human malignant melanoma cells.
    Notter M, Schirrmacher V.
    Int J Cancer; 1990 May 15; 45(5):834-41. PubMed ID: 2159436
    [Abstract] [Full Text] [Related]

  • 15. Efficient class II major histocompatibility complex presentation of endogenously synthesized hepatitis C virus core protein by Epstein-Barr virus-transformed B-lymphoblastoid cell lines to CD4(+) T cells.
    Chen M, Shirai M, Liu Z, Arichi T, Takahashi H, Nishioka M.
    J Virol; 1998 Oct 15; 72(10):8301-8. PubMed ID: 9733874
    [Abstract] [Full Text] [Related]

  • 16. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
    Alexander MA, Bennicelli J, Guerry D.
    J Immunol; 1989 Jun 01; 142(11):4070-8. PubMed ID: 2469732
    [Abstract] [Full Text] [Related]

  • 17. Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma.
    Kharkevitch DD, Seito D, Balch GC, Maeda T, Balch CM, Itoh K.
    Int J Cancer; 1994 Aug 01; 58(3):317-23. PubMed ID: 7914181
    [Abstract] [Full Text] [Related]

  • 18. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
    Enssle KH, Fleischer B.
    Clin Exp Immunol; 1990 Mar 01; 79(3):409-15. PubMed ID: 1690617
    [Abstract] [Full Text] [Related]

  • 19. Lentivirus vector-mediated expression of tumor-associated epitopes by human antigen presenting cells.
    Lizée G, Gonzales MI, Topalian SL.
    Hum Gene Ther; 2004 Apr 01; 15(4):393-404. PubMed ID: 15053864
    [Abstract] [Full Text] [Related]

  • 20. CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells.
    Long HM, Zuo J, Leese AM, Gudgeon NH, Jia H, Taylor GS, Rickinson AB.
    Blood; 2009 Jul 23; 114(4):807-15. PubMed ID: 19443664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 217.